Where is iqvia headquartered

Overview

IQVIA is a multinational corporation specializing in healthcare data analytics, clinical research, and technology services. The company was formed in 2016 through the merger of IMS Health, founded in 1954, and Quintiles, founded in 1982. This strategic combination created one of the world's largest healthcare information services and clinical research organizations. The merger brought together IMS Health's extensive healthcare data and analytics capabilities with Quintiles' clinical research expertise.

Headquartered in Durham, North Carolina, IQVIA operates globally with a presence in over 100 countries. The company's name combines "IQ" representing intelligence and "VIA" representing the pathway or channel through which insights are delivered. Since its formation, IQVIA has grown to become a Fortune 500 company with significant influence in pharmaceutical development, healthcare analytics, and commercial services. The company's Durham headquarters serves as the central hub for its global operations and strategic decision-making.

How It Works

IQVIA operates through three primary business segments that leverage data, technology, and analytics to serve healthcare clients worldwide.

• Technology & Analytics Solutions: This segment provides advanced analytics, real-world evidence, and technology platforms that help pharmaceutical companies, healthcare providers, and payers make data-driven decisions. IQVIA processes data from over 1.5 million data feeds globally, covering more than 1 billion patient encounters annually. The company's proprietary information assets include one of the world's largest collections of healthcare information, with data spanning 850,000 data suppliers across 100+ countries.
• Research & Development Solutions: IQVIA offers comprehensive clinical research services, managing clinical trials from Phase I through Phase IV. The company has supported over 20,000 clinical trials since 2016 and maintains relationships with more than 1.5 million investigative site staff worldwide. Their services include protocol design, site selection, patient recruitment, data management, and regulatory submission support across therapeutic areas.
• Contract Sales & Medical Solutions: This segment provides outsourced commercial services including sales teams, medical science liaisons, and market access support. IQVIA deploys over 15,000 field-based professionals globally who engage with healthcare providers on behalf of pharmaceutical and biotechnology clients. The company's commercial solutions help clients optimize product launches and maximize market penetration.
• Real-World Solutions: IQVIA leverages real-world data from electronic health records, claims databases, and patient registries to generate evidence about treatment patterns, outcomes, and healthcare utilization. The company maintains access to de-identified data representing over 600 million patient lives globally, enabling longitudinal studies and comparative effectiveness research across multiple therapeutic areas.

Key Comparisons

Why It Matters

• Accelerating Drug Development: IQVIA's integrated approach combining data analytics with clinical research helps reduce drug development timelines by an average of 30%. The company's technologies and methodologies have contributed to bringing over 100 new therapies to market annually, addressing critical healthcare needs across therapeutic areas including oncology, rare diseases, and chronic conditions.
• Improving Healthcare Outcomes: By analyzing real-world evidence from millions of patient records, IQVIA enables healthcare stakeholders to understand treatment effectiveness in diverse populations. Their insights help identify optimal treatment pathways, reduce healthcare costs by approximately 15-20% through better resource allocation, and support value-based care initiatives that prioritize patient outcomes over service volume.
• Supporting Pandemic Response: During the COVID-19 pandemic, IQVIA played a crucial role in accelerating vaccine and therapeutic development. The company supported over 300 COVID-19 related studies and trials, contributing to the development and distribution of vaccines that reached billions of people worldwide. Their data analytics helped track pandemic spread and treatment outcomes across multiple regions.

Looking forward, IQVIA continues to expand its capabilities in artificial intelligence, machine learning, and digital health technologies. The company is investing in next-generation platforms that will further accelerate clinical research and enhance healthcare decision-making. As healthcare becomes increasingly data-driven and personalized, IQVIA's position at the intersection of data analytics, technology, and clinical expertise positions it to play an even more significant role in shaping the future of medicine and improving patient outcomes globally. The company's Durham headquarters will remain central to these innovations, serving as the nerve center for global healthcare intelligence operations.